Lonza Group Ltd
O6Z
Company Profile
Business description
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Contact
Muenchensteinerstrasse 38
Basel4002
CHET: +41 613168111
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
18,686
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,775.00 | 4.40 | 0.05% |
CAC 40 | 7,742.24 | 57.56 | 0.75% |
DAX 40 | 23,699.12 | 182.89 | 0.78% |
Dow JONES (US) | 42,515.09 | 317.30 | 0.75% |
FTSE 100 | 8,875.22 | 24.59 | 0.28% |
HKSE | 24,060.99 | 168.43 | 0.70% |
NASDAQ | 19,701.21 | 294.39 | 1.52% |
Nikkei 225 | 38,311.33 | 477.08 | 1.26% |
NZX 50 Index | 12,690.13 | 137.26 | 1.09% |
S&P 500 | 6,033.11 | 56.14 | 0.94% |
S&P/ASX 200 | 8,548.40 | 1.00 | 0.01% |
SSE Composite Index | 3,388.73 | 11.73 | 0.35% |